Haibin Liang

No. 1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Corrigendum to "LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway" [Cancer Lett. 372 (2016) 239-250].

Corrigendum to "LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway" [Cancer Lett. 372 (2016) 239-250].

Journal: Cancer letters

Published: March 26, 2025

Integrating single-cell and multi-omic approaches reveals Euphorbiae Humifusae Herba-dependent mitochondrial dysfunction in non-small-cell lung cancer.

Integrating single-cell and multi-omic approaches reveals Euphorbiae Humifusae Herba-dependent mitochondrial dysfunction in non-small-cell lung cancer.

Journal: Journal of cellular and molecular medicine

Published: February 21, 2024

Association between Gastric Cancer and 12 Autoimmune Diseases: A Mendelian Randomization Study.

Association between Gastric Cancer and 12 Autoimmune Diseases: A Mendelian Randomization Study.

Journal: Genes

Published: August 08, 2023

EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression.

EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression.

Journal: Cancer letters

Published: July 30, 2023

Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108].

Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108].

Journal: Cancer letters

Published: October 10, 2022

Correction to: Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer.

Correction to: Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 04, 2022

Machine Learning-based Correlation Study between Perioperative Immunonutritional Index and Postoperative Anastomotic Leakage in Patients with Gastric Cancer.

Machine Learning-based Correlation Study between Perioperative Immunonutritional Index and Postoperative Anastomotic Leakage in Patients with Gastric Cancer.

Journal: International journal of medical sciences

Published: February 19, 2022

Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation.

Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation.

Journal: International journal of biological sciences

Published: December 29, 2021

Correction: EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.

Correction: EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.

Journal: Cell death & disease

Published: December 21, 2021

RAB43 Promotes Gastric Cancer Cell Proliferation and Metastasis via Regulating the PI3K/AKT Signaling Pathway.

RAB43 Promotes Gastric Cancer Cell Proliferation and Metastasis via Regulating the PI3K/AKT Signaling Pathway.

Journal: OncoTargets and therapy

Published: November 05, 2019

Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer.

Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 05, 2019

NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma.

NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma.

Journal: Cancer science

Published: May 13, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026